Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Will Editas Medicine (EDIT) Report Negative Q1 Earnings? What You Should Know
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
Why Is Editas (EDIT) Down 26.2% Since Last Earnings Report?
1 Wall Street Analyst Raises Editas Medicine's Price Target by 45%. Here's Why She's Right.
Insider Sells Shares of Editas Medicine Inc (EDIT)
1 Beaten-Down Stock With 55% Upside, According to Wall Street
Why Editas Medicine Stock Soared as Much as 42% Higher This Week
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.